Although Nrg4 had a low cut-off point, both Nrg4 and adiponectin levels were associated with the degree of metabolic disorders, suggesting the potential to predict the occurrence or risk of metabolic disease in children and adolescents with obesity. Here, ADIPOQ is linked to metabolic disease.